Drugs used in secondary prevention after myocardial infarction: case presentation.
作者信息
Maxwell S, Waring W S
机构信息
Clinical Pharmacology Unit, The University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU.
出版信息
Br J Clin Pharmacol. 2000 Nov;50(5):405-17. doi: 10.1046/j.1365-2125.2000.00287.x.
Abstract
摘要
相似文献
1
Drugs used in secondary prevention after myocardial infarction: case presentation.心肌梗死后二级预防用药：病例报告
Br J Clin Pharmacol. 2000 Nov;50(5):405-17. doi: 10.1046/j.1365-2125.2000.00287.x.
2
[Secondary prevention in patients after myocardial infarction by means of Tromcardin forte (author's transl)].通过强力曲美他嗪（作者译）对心肌梗死后患者进行二级预防
Cas Lek Cesk. 1974 May 31;113(21-22):672-7.
3
An early intervention secondary prevention study with oxprenolol following myocardial infarction.一项心肌梗死后使用氧烯洛尔的早期干预二级预防研究。
Eur Heart J. 1981 Oct;2(5):389-93. doi: 10.1093/oxfordjournals.eurheartj.a061223.
4
Management of patients after their first myocardial infarction.首次心肌梗死后患者的管理。
BMJ. 1994 Oct 29;309(6962):1129-34. doi: 10.1136/bmj.309.6962.1129.
5
Secondary prevention of myocardial infarction: new horizons for pharmacotherapy. Introduction.心肌梗死的二级预防：药物治疗的新视野。引言。
Eur Heart J. 1996 Dec;17 Suppl F:1-2.
6
Which patients should receive beta-blocking drugs after myocardial infarction?哪些心肌梗死患者应接受β受体阻滞剂治疗？
Eur Heart J. 1983 Jul;4 Suppl D:161-6. doi: 10.1093/eurheartj/4.suppl_d.161.
7
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.ST段抬高型急性心肌梗死患者的管理。欧洲心脏病学会急性心肌梗死管理特别工作组。
Eur Heart J. 2003 Jan;24(1):28-66. doi: 10.1016/s0195-668x(02)00618-8.
8
[Heparin in the treatment and secondary prevention of myocardial infarction. A critical review of the main trials].[肝素在心肌梗死治疗及二级预防中的应用。主要试验的批判性综述]
Arch Mal Coeur Vaiss. 1991 Nov;84(11):1581-6.
9
10
Office care of patients after myocardial infarction.心肌梗死后患者的门诊护理。
Postgrad Med. 2008 Apr;120(1):11-7. doi: 10.3810/pgm.2008.04.1755.
引用本文的文献
1
Hyperhomocysteinemia Causing Myocardial Infarction in a Young Patient: A Case Report.高同型半胱氨酸血症致青年患者心肌梗死一例报告
Cureus. 2025 Jan 14;17(1):e77421. doi: 10.7759/cureus.77421. eCollection 2025 Jan.
2
Medical care of acute myocardial infarction patients in a resource limiting country, Trinidad: a cross-sectional retrospective study.资源有限国家特立尼达急性心肌梗死患者的医疗护理：一项横断面回顾性研究。
BMC Health Serv Res. 2019 Jul 18;19(1):501. doi: 10.1186/s12913-019-4344-2.
本文引用的文献
1
Vitamin E supplementation and cardiovascular events in high-risk patients.高危患者补充维生素E与心血管事件
N Engl J Med. 2000 Jan 20;342(3):154-60. doi: 10.1056/NEJM200001203420302.
2
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.血管紧张素转换酶抑制剂雷米普利对高危患者心血管事件的影响。
N Engl J Med. 2000 Jan 20;342(3):145-53. doi: 10.1056/NEJM200001203420301.
3
Emergency management of acute myocardial infarction.急性心肌梗死的急诊处理
Br J Clin Pharmacol. 1999 Sep;48(3):284-98. doi: 10.1046/j.1365-2125.1999.00998.x.
4
5
Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.英国关于临床实践中冠心病预防的联合建议。英国心脏病学会、英国高脂血症协会、英国高血压学会，获英国糖尿病协会认可。
Heart. 1998 Dec;80 Suppl 2(Suppl 2):S1-29.
6
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.心脏不全比索洛尔研究II（CIBIS-II）：一项随机试验。
Lancet. 1999 Jan 2;353(9146):9-13.
7
Aspirin: benefit and risk in thromboprophylaxis.阿司匹林：血栓预防中的益处与风险。
QJM. 1998 Aug;91(8):523-38. doi: 10.1093/qjmed/91.8.523.
8
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.雌激素加孕激素用于绝经后妇女冠心病二级预防的随机试验。心脏与雌激素/孕激素替代研究（HERS）研究组
JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605.
9
The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial.植入式自动心脏除颤器的成本效益：多中心自动除颤器植入试验（MADIT）的结果。
Circulation. 1998 Jun 2;97(21):2129-35. doi: 10.1161/01.cir.97.21.2129.
10
ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.ISIS-2研究：疑似急性心肌梗死患者在静脉注射链激酶、口服阿司匹林、两者联合或两者均不用的随机对照试验中的10年生存率。ISIS-2（第二项心肌梗死生存国际研究）协作组
BMJ. 1998 May 2;316(7141):1337-43. doi: 10.1136/bmj.316.7141.1337.
Zotero 插件